Histogenics (NASDAQ:HSGX) Sees Strong Trading Volume
Histogenics Corp (NASDAQ:HSGX) saw strong trading volume on Wednesday . 54,039,674 shares were traded during trading, an increase of 437% from the previous session’s volume of 10,059,263 shares.The stock last traded at $0.30 and had previously closed at $0.22.
The firm has a market cap of $28.39 million, a P/E ratio of -0.37 and a beta of 3.46.
A number of hedge funds have recently made changes to their positions in HSGX. Geode Capital Management LLC purchased a new stake in Histogenics during the fourth quarter valued at approximately $25,000. Virtu Financial LLC increased its holdings in Histogenics by 505.8% during the first quarter. Virtu Financial LLC now owns 592,976 shares of the biotechnology company’s stock valued at $69,000 after buying an additional 495,096 shares during the last quarter. Finally, Sabby Management LLC purchased a new stake in Histogenics during the first quarter valued at approximately $220,000. 11.37% of the stock is owned by institutional investors and hedge funds.
Histogenics Company Profile (NASDAQ:HSGX)
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Receive News & Ratings for Histogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogenics and related companies with MarketBeat.com's FREE daily email newsletter.